Skip to content
10-Q

Quarterly Report

BioDelivery Sciences International, Inc.

0001103021-21-000106

← back to feed
Filed
Nov 3, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 3, 2021 98.8M sh
Shares Diluted Q3 2021 · Sep 30, 2021 102.43M sh
Shares Diluted Q3 2021 · Sep 30, 2021 103.47M sh
Shares Diluted Q3 2021 · Sep 30, 2020 105.78M sh
Shares Diluted Q3 2021 · Sep 30, 2020 104.84M sh
Stock Repurchased Q3 2021 · Sep 30, 2021 $11.9M
Stock Repurchased Q3 2021 · Sep 30, 2020 $0
Capex Q3 2021 · Sep 30, 2021 $415K
Capex Q3 2021 · Sep 30, 2020 $0
Operating Cash Flow Q3 2021 · Sep 30, 2021 $27.29M
Operating Cash Flow Q3 2021 · Sep 30, 2020 $13.97M
Cash And Equivalents Q3 2021 · Sep 30, 2021 $100.71M
Cash And Equivalents Q3 2021 · Dec 31, 2020 $111.58M
Stockholders Equity Q3 2021 · Sep 30, 2021 $122.78M
Stockholders Equity Q3 2021 · Jun 30, 2021 $113.92M
Stockholders Equity Q3 2021 · Mar 31, 2021 $108.85M
Stockholders Equity Q3 2021 · Dec 31, 2020 $108.23M
Stockholders Equity Q3 2021 · Sep 30, 2020 $95.89M
Stockholders Equity Q3 2021 · Jun 30, 2020 $84.77M
Stockholders Equity Q3 2021 · Mar 31, 2020 $76.59M
Stockholders Equity Q3 2021 · Dec 31, 2019 $69.76M
Current Liabilities Q3 2021 · Sep 30, 2021 $77.66M
Current Liabilities Q3 2021 · Dec 31, 2020 $53M
Total Liabilities Q3 2021 · Sep 30, 2021 $133.3M
Total Liabilities Q3 2021 · Dec 31, 2020 $131.66M
Current Assets Q3 2021 · Sep 30, 2021 $188.26M
Current Assets Q3 2021 · Dec 31, 2020 $182.39M
Total Assets Q3 2021 · Sep 30, 2021 $256.07M
Total Assets Q3 2021 · Dec 31, 2020 $239.89M
Eps Diluted Q3 2021 · Sep 30, 2021 $0.07
Eps Diluted Q3 2021 · Sep 30, 2021 $0.20
Eps Diluted Q3 2021 · Sep 30, 2020 $0.09
Eps Diluted Q3 2021 · Sep 30, 2020 $0.15
Eps Basic Q3 2021 · Sep 30, 2021 $0.07
Eps Basic Q3 2021 · Sep 30, 2021 $0.21
Eps Basic Q3 2021 · Sep 30, 2020 $0.09
Eps Basic Q3 2021 · Sep 30, 2020 $0.16
Net Income Q3 2021 · Sep 30, 2021 $6.67M
Net Income Q3 2021 · Sep 30, 2021 $20.97M
Net Income Q3 2021 · Jun 30, 2021 $9.06M
Net Income Q3 2021 · Mar 31, 2021 $5.24M
Net Income Q3 2021 · Dec 31, 2020 $10.2M
Net Income Q3 2021 · Sep 30, 2020 $9.38M
Net Income Q3 2021 · Sep 30, 2020 $15.52M
Net Income Q3 2021 · Jun 30, 2020 $1.17M
Net Income Q3 2021 · Mar 31, 2020 $4.97M
Operating Income Q3 2021 · Sep 30, 2021 $9.26M
Operating Income Q3 2021 · Sep 30, 2021 $28.07M
Operating Income Q3 2021 · Sep 30, 2020 $11.61M
Operating Income Q3 2021 · Sep 30, 2020 $20.53M
Revenue Q3 2021 · Sep 30, 2021 $41.09M
Revenue Q3 2021 · Sep 30, 2021 $123.55M
Revenue Q3 2021 · Sep 30, 2020 $39.44M
Revenue Q3 2021 · Sep 30, 2020 $114.3M